IN8bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. 

CEO
William T. Ho
CEOWilliam T. Ho
Employees
31
Employees31
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
31
Employees31

INAB Key Statistics

Market cap
51.51M
Market cap51.51M
Price-Earnings ratio
-1.16
Price-Earnings ratio-1.16
Dividend yield
Dividend yield
Average volume
194.13K
Average volume194.13K
High today
$1.27
High today$1.27
Low today
$1.16
Low today$1.16
Open price
$1.20
Open price$1.20
Volume
93.62K
Volume93.62K
52 Week high
$3.95
52 Week high$3.95
52 Week low
$0.65
52 Week low$0.65
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.